Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Bianka, Müller"'
Autor:
Giinter Krause, Michael Hallek, Nche Forcob, Christian Klein, Polina Isaeva, Pablo Umana, Clemens-Martin Wendtner, Bianka Müller, Michaela Patz, Lukas P. Frenzel
Publikováno v:
British Journal of Haematology. 152:295-306
The effects of two CD20 antibodies, namely rituximab, the current standard for treatment of chronic lymphocytic leukaemia (CLL) in combination with chemotherapy, and GA101, a glyco-engineered type II antibody were compared on CLL cells ex vivo. Antib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::970fe890d5b7aa97934081bcf3e5e15e
https://doi.org/10.1111/j.1365-2141.2010.08428.x
https://doi.org/10.1111/j.1365-2141.2010.08428.x
Autor:
Michaela, Patz, Polina, Isaeva, Nche, Forcob, Bianka, Müller, Lukas P, Frenzel, Clemens-Martin, Wendtner, Christian, Klein, Pablo, Umana, Michael, Hallek, Günter, Krause
Publikováno v:
British journal of haematology. 152(3)
The effects of two CD20 antibodies, namely rituximab, the current standard for treatment of chronic lymphocytic leukaemia (CLL) in combination with chemotherapy, and GA101, a glyco-engineered type II antibody were compared on CLL cells ex vivo. Antib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b5116656e01f64c1f866b2a0945414d6
https://pubmed.ncbi.nlm.nih.gov/21155758
https://pubmed.ncbi.nlm.nih.gov/21155758
Autor:
Günter Krause, Michael Hallek, Christian Klein, Nche Forcob, Bianka Müller, Pablo Umana, Michaela Patz
Publikováno v:
Web of Science
Abstract 2365 Poster Board II-342 Introduction: Monoclonal antibodies against CD20 have great potential as therapeutics for the treatment of B-cell lymphomas and chronic lymphocytic leukemia (CLL), since CD20 is expressed on all mature B-cells except
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4d1cf057dceb278fead946e87a94113
https://doi.org/10.1182/blood.v114.22.2365.2365
https://doi.org/10.1182/blood.v114.22.2365.2365